[1]Wieland;Mangner;Inbasekaran;Brown;Wu[JournalofMedicinalChemistry,1984,vol.27,#2,p.149-155]
[1]Trtic,T.;Maksin,T.;Vuksanovic,L.;Zagar,I.[Journaloflabelledcompoundsandradiopharmaceuticals,1997,vol.40,p.114-116]
80663-95-2
878207-28-4 | Methyl 2-bromo-4,5-difluorobenzoate | AA004JYP | MFCD08458104
86153-25-5 | 7-Bromo-1h-indole-3-carboxylic acid | AA004KRZ | MFCD07369966
87294-97-1 | 4-(Morpholine-4-carbonyl)benzonitrile | AA004LOD | MFCD02293747
874289-15-3 | 3-Fluoro-4-(propylcarbamoyl)phenylboronic acid | AA004ME6 | MFCD09258737
86734-59-0 | 3-(Benzyloxy)-2-hydroxybenzaldehyde | AA004N8Q | MFCD26385136
851179-00-5 | 3-Chloro-2,5-difluoropyridine | AA004O20 | MFCD09998887
871329-61-2 | 3-(Pyrrolidinylsulfonyl)phenylboronic acid | AA004OQK | MFCD07783851
850567-26-9 | 3-(Methoxycarbamoyl)phenylboronic acid | AA004P9R | MFCD04115698
852227-96-4 | 1-[4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]piperidine | AA004Q67 | MFCD07368524
86827-08-9 | Methyl n-cbz-3-piperidineacetate | AA004QVQ | MFCD02179007